Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics
Go back to Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics| (NASDAQ: BIOT) | Delayed: 10.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.15 | 52 Week High | $ | |||
| Open | $10.15 | 52 Week Low | $ | |||
| Day High | $10.15 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $ | |||
| Volume | 6,502 | |||||
